Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum

D'Orazio, 2011, Biosensors in clinical chemistry, Clin Chim Acta, 412, 1749, 10.1016/j.cca.2011.06.025

Szturmowicz, 1995, 1268 Is an increased carcinoembryonic antigen (CEA) concentration in pericardial fluid an indication of malignant pericarditis?, Eur J Cancer, 31, S264, 10.1016/0959-8049(95)96514-E

Villena, 1996, Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9, Cancer, 78, 736, 10.1002/(SICI)1097-0142(19960815)78:4<736::AID-CNCR7>3.0.CO;2-C

Behera, 1997, Carcinoembryonic antigen and sialic acid levels (total and lipid bound) in patients with lung cancer, Lung Cancer, 18, 168

Wang, 2004, EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer, Hepato-Gastroenterology, 51, 136

Liew, 2007, Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples, BioTech, 42, 327, 10.2144/000112332

Park, 2012, Evaluation of the UniCel™ DxI 800 immunoassay analyzer in measuring five tumor markers, Yonsei Med J, 53, 557, 10.3349/ymj.2012.53.3.557

Yan, 2005, Flow injection immunoassay for carcinoembryonic antigen combined with time-resolved fluorometric detection, J Immunol Methods, 305, 120, 10.1016/j.jim.2005.03.004

Hou, 2012, Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum, Anal Chim Acta, 734, 93, 10.1016/j.aca.2012.04.044

Chen, 2013, A novel homogeneous time-resolved fluoroimmunoassay for carcinoembryonic antigen based on water-soluble quantum dots, J Fluoresc, 23, 649, 10.1007/s10895-013-1175-0

Xin, 2008, Microplate chemiluminescence enzyme immunoassay for the determination of carcinoembryonic antigen in human serum, Chin J Anal Chem, 36, 1056, 10.1016/S1872-2040(08)60058-4

Xue, 2011, Chemiluminescent analysis of carcinoembryonic antigen in serum samples, Chin J Anal Chem, 39, 95

Qu, 2013, A rapid and highly sensitive portable chemiluminescent immunosensor of carcinoembryonic antigen based on immunomagnetic separation in human serum, Anal Chim Acta, 766, 94, 10.1016/j.aca.2012.12.043

Wang, 2012, Application of indium tin oxide device in gold-coated magnetic iron solid support enhanced electrochemiluminescent immunosensor for determination of carcinoma embryonic antigen, Sensors Actuators B, 171–172, 891, 10.1016/j.snb.2012.05.091

Kricka, 1998, Miniaturization of analytical systems, Clin Chem, 44, 2008, 10.1093/clinchem/44.9.2008

Choi, 2010, Nanotechnology for early cancer detection, Sensors, 10, 428, 10.3390/s100100428

Ferrari, 2005, Cancer nanotechnology: opportunities and challenges, Nat Rev Cancer, 5, 161, 10.1038/nrc1566

Ludwig, 2005, Biomarkers in cancer staging, prognosis and treatment selection, Nat Rev Cancer, 5, 845, 10.1038/nrc1739

Kingsmore, 2006, Multiplexed protein measurement: technologies and applications of protein and antibody arrays, Nat Rev Drug Discov, 5, 310, 10.1038/nrd2006

Choi, 2002, An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities, Lab Chip, 2, 27, 10.1039/b107540n

Thomas, 2004, Microbead-based electrochemical immunoassay with interdigitated array electrodes, Anal Biochem, 328, 113, 10.1016/j.ab.2004.02.020

Zhang, 2006, Gold-coated magnetic particles for solid-phase immunoassays: enhancing immobilized antibody binding efficiency and analytical performance, Anal Chem, 78, 609, 10.1021/ac051720x

Centi, 2007, Aptamer-based detection of plasma proteins by an electrochemical assay coupled to magnetic beads, Anal Chem, 79, 1466, 10.1021/ac061879p

Tsai, 2007, Detection of C-reactive protein based on immunoassay using antibody-conjugated magnetic nanoparticles, Anal Chem, 79, 8416, 10.1021/ac071262n

Wang, 2008, Electrochemical immunoassay of carcinoembryonic antigen based on a lead sulfide nanoparticle label, Nanotechnology, 19, 435501, 10.1088/0957-4484/19/43/435501

Franzreb, 2006, Protein purification using magnetic adsorbent particles, Appl Microbiol Biotechnol, 70, 505, 10.1007/s00253-006-0344-3

Mani, 2011, Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring, Expert Opin Med Diagn, 5, 381, 10.1517/17530059.2011.607161

Xie, 2012, Magnetic nanoparticle-based theranostics, Theranostics, 2, 122, 10.7150/thno.4051

Liu, 2004, Electrochemical coding for multiplexed immunoassays of proteins, Anal Chem, 76, 7126, 10.1021/ac049107l

Laurence, 1975, First British standard for carcinoembryonic antigen (CEA), Br J Cancer, 32, 295, 10.1038/bjc.1975.227

Martinez-Mancera, 2014, Physical characterization and photoluminescence properties of thioglycolic acid-stabilized lead sulfide nanocrystals, Mater Chem Phys, 148, 1045, 10.1016/j.matchemphys.2014.09.016

Hermanson, 2008, Bioconjugate techniques, 595

de la Escosura-Muñiz, 2009, Chapter 10: Electrochemical immunosensing using micro and nanoparticles, 145, 10.1007/978-1-60327-569-9_10

Zumbrägel, 2011, Electrochemistry, 55

Zumbrägel, 2011, Electrochemistry, 56

O'Connell, 1993, Calibration and assay development using the four-parameter logistic model, Chemom Intell Lab Syst, 20, 97, 10.1016/0169-7439(93)80008-6

Proll, 2005, Fully automated biosensors for water analysis, Anal Bioanal Chem, 381, 61, 10.1007/s00216-004-2897-2

Dudley, 1985, Guidelines for immunoassay data processing, Clin Chem, 31, 1264, 10.1093/clinchem/31.8.1264

Little, 2004, Comparison of curve fitting models for ligand binding assays, Chromatographia Suppl, 59, S177, 10.1365/s10337-003-0182-8

Findlay, 2007, Appropriate calibration curve fitting in ligand binding assays, AAPS J, 9, E260, 10.1208/aapsj0902029

Inczedy, 1998, The orange book

Stöckl, 1998, Validity of linear regression in method comparison studies: is it limited by the statistical model or the quality of the analytical input data?, Clin Chem, 44, 2340, 10.1093/clinchem/44.11.2340

Deming, 1943

Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, 307, 10.1016/S0140-6736(86)90837-8

Boehm, 1996, Extended glycoprotein structure of the seven domains in human carcinoembryonic antigen by X-ray and neutron solution scattering and an automated curve fitting procedure: Implications for cellular adhesion, J Mol Biol, 259, 718, 10.1006/jmbi.1996.0353

Fragoso, 2012, Chapter 33: Electrochemical immunosensor for detection of proteic cancer markers, 573

Delgado, 2001, Standardization of carcinoembryonic antigen testing in the setting of clinical laboratory consolidation, Lab Med, 32, 92, 10.1309/XNAR-H5H3-YMCX-6CDF

Molina, 1998, c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value, Breast Cancer Res Treat, 51, 109, 10.1023/A:1005734429304

Lumsden, 2000, Laboratory test method validation, Revue Méd Vét, 151, 623

2009, A practical guide to internal quality control (IQC) for quantitative tests in medical laboratories (proposed guidelines)

Westgard, 1981, Precision and accuracy: concepts and assessment by method evaluation testing, Crit Rev Clin Lab Sci, 13, 283, 10.3109/10408368109106450

Mujagić, 2004, The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients, Med Arh, 58, 23

Carey, 1989, Evaluation of methods in clinical chemistry, 290

Passing, 1983, A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I, J Clin Chem Clin Biochem, 21, 709

Linnet, 1993, Evaluation of regression procedures for methods comparison studies, Clin Chem, 39, 424, 10.1093/clinchem/39.3.424

NCCLS, 2002, Method comparison and bias estimation using patient samples; approved guideline